Leukocyte rolling in postcapillary venules of inflamed tissues is reduced in L-selectin–deficient mice and mice treated with L-selectin blocking antibodies, but the glycoprotein ligand for L-selectin in inflamed venules is unknown. Here, we show that L-selectin–dependent rolling after P-selectin blockade is completely absent in P-selectin glycoprotein ligand-1 (PSGL-1)−/− mice or wild-type mice treated with a PSGL-1 blocking monoclonal antibody. Immunohistochemistry and flow cytometry failed to show PSGL-1 expression on resting or inflamed endothelium or on platelets. To investigate whether leukocyte-expressed PSGL-1 is mediating L-selectin–dependent rolling, we reconstituted lethally irradiated wild-type mice with PSGL-1−/− bone marrow cells. These chimeric mice showed no L-selectin–dependent rolling, suggesting that leukocyte-expressed PSGL-1 mediates L-selectin–dependent rolling. Frame-to-frame video analysis of L-selectin–dependent rolling in wild-type mice showed that the majority of observed L-selectin–dependent leukocyte rolling was between free flowing leukocytes and already adherent leukocytes or possibly leukocyte fragments, followed by E-selectin–dependent leukocyte rolling along the endothelium. Leukocyte rolling was significantly slower for leukocyte–endothelial than leukocyte–leukocyte interactions. We conclude that leukocyte-expressed PSGL-1 serves as the main L-selectin ligand in inflamed postcapillary venules. L-selectin binding to PSGL-1 initiates tethering events that enable L-selectin–independent leukocyte-endothelial interactions. These findings provide a molecular mechanism for the inflammatory defects seen in L-selectin–deficient mice.
Skip Nav Destination
Article navigation
19 May 2003
Article|
May 19 2003
P-selectin Glycoprotein Ligand-1 Mediates L-Selectin–dependent Leukocyte Rolling in Venules
Markus Sperandio,
Markus Sperandio
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908
3Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Search for other works by this author on:
Michael L. Smith,
Michael L. Smith
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908
Search for other works by this author on:
S. Bradley Forlow,
S. Bradley Forlow
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908
Search for other works by this author on:
Timothy S. Olson,
Timothy S. Olson
2Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908
Search for other works by this author on:
Lijun Xia,
Lijun Xia
3Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Search for other works by this author on:
Rodger P. McEver,
Rodger P. McEver
3Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
4Department of Biochemistry and Molecular Biology, Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104
Search for other works by this author on:
Klaus Ley
Klaus Ley
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908
2Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908
Search for other works by this author on:
Markus Sperandio
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908
3Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Michael L. Smith
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908
S. Bradley Forlow
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908
Timothy S. Olson
2Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908
Lijun Xia
3Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
Rodger P. McEver
3Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
4Department of Biochemistry and Molecular Biology, Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104
Klaus Ley
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908
2Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908
Address correspondence to Klaus Ley, University of Virginia Health System, Cardiovascular Research Center, MR5 Bldg, Rm. 1013, P.O. Box 801 394, Charlottesville, VA 22908-1394. Phone: 434-243-9966; Fax: 434-982-3870; E-mail: [email protected]
This online version of this article contains supplemental material.
M. Sperandio's present address is Neonatal Unit, Children's Hospital, University of Heidelberg, Heidelberg 69120, Germany.
*
Abbreviations used in this paper: HUVEC, human umbilical vein endothelial cell; PSGL, P-selectin glycoprotein ligand-1.
Received:
October 24 2002
Revision Received:
April 09 2003
Accepted:
April 09 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 197 (10): 1355–1363.
Article history
Received:
October 24 2002
Revision Received:
April 09 2003
Accepted:
April 09 2003
Citation
Markus Sperandio, Michael L. Smith, S. Bradley Forlow, Timothy S. Olson, Lijun Xia, Rodger P. McEver, Klaus Ley; P-selectin Glycoprotein Ligand-1 Mediates L-Selectin–dependent Leukocyte Rolling in Venules . J Exp Med 19 May 2003; 197 (10): 1355–1363. doi: https://doi.org/10.1084/jem.20021854
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement